Business Wire

WORLDREMIT

21.10.2020 14:10:09 CEST | Business Wire | Press release

Share
WorldRemit Sees Remittances to Zimbabwe Double in Six Months and Introduces New Retail Partnership With OK Zimbabwe

Earlier this year, the World Bank forecasted that in the wake of the Covid-19 economic crisis, remittance flows to Sub Saharan Africa would fall by 23.1%. However today, WorldRemit , the global online money transfer service has reported that the demand for their remittance services to Zimbabwe continues to grow at an accelerated rate and has doubled in the last six months for the company.

The company reports that this accelerated growth is driven by the number of cash collection points being made available during Covid-19. Key partnerships have been formed with companies such as Mukuru and more recently OK Stores to increase its customer footprint into both rural and peri-urban areas and to further extend trading hours.

Pardon Mujakachi, Head of Sub Saharan Africa and Country Director for Zimbabwe at WorldRemit said “We are continuously looking at how we respond to the increasing demand for our product in the diaspora and innovate payout options for customers at home. The customer demand creates opportunity for growth and the expansion of our footprint especially in the hard to reach areas of Zimbabwe. Our aim is to ensure that everyone everywhere has access to our service”.

Zimbabweans in the diaspora are driving the exponential growth as they increasingly embrace the benefits of the digital platform offered by WorldRemit. The money transfer service is said to offer the lowest fees to Zimbabwe from over 50+ send countries including the UK, USA, Canada, Australia, New Zealand and South Africa. “Our digital model offers customers the convenience to transact on the go whilst providing a fast and affordable experience for sending money home to loved ones.” Mujakachi added.

In partnership with OK Zimbabwe and powered by Countitouch Technologies, WorldRemit has launched a new payout service that allows Zimbabweans to now receive remittances, instantly shop and collect cash from across 64 OK Zimbabwe store locations. “This retail partnership with OK Zimbabwe - powered by Countitouch Technologies is a first of its kind for us. Our first retail partner offers a cash guarantee and with the convenience, speed and security we offer our customers, now everyday is a remittance day. The OK Zimbabwe retail network is the widest in the country and offers us the opportunity to expand the depth of our remittance services for Zimbabweans.” said Mujakachi.

OK Zim has a footfall of approximately 70million people visiting their retail stores per month, six days a week. Currently open from 8am to 6.30pm, WorldRemit customers can send remittances 24/7 and their recipients can receive cash with more convenience and choice across a network of over 80 branches.

Post pandemic, OK Zim stores will extend its trading hours 8am to 8pm, 7 days per week. Mujakachi adds, “Our extensive cash collection network, flexible cash collection hours and lower fees, offer value for money to our customers. This proves us to be the most affordable means of sending money to Zimbabwe.”

-ends-

About WorldRemit

WorldRemit is a leading fintech providing international money transfer services. We disrupted an industry previously dominated by offline legacy players by taking international money transfers online - making them safer, faster and lower-cost. We currently send from 50 to 150 countries, operate in 6,500 money transfer corridors worldwide and employ over 1,100 people worldwide.

On the sending side WorldRemit is 100% digital (cashless), increasing convenience and enhancing security. For those receiving money, the company offers a wide range of options including bank deposit, cash collection, mobile airtime top-up and mobile money.

Backed by Accel, TCV and Leapfrog – WorldRemit’s headquarters are in London, United Kingdom with a global presence in the United States, Canada, South Africa, Japan, Singapore, the Philippines, Australia and New Zealand.

www.worldremit.com

About OK Zimbabwe

OK Zimbabwe Limited has been in existence since 1942, and has established itself as a customer-oriented retail organization providing comprehensive access to a broad range of retail products and allied services developed in response to its customers' requirements for convenience and value.

The Group is a leading supermarket retailer whose business covers three major categories, comprising groceries, basic clothing and textiles and houseware products. The groceries category includes dry groceries, butchery, delicatessen, takeaway, bakery, provisions and fruit and vegetable sections. OK Zimbabwe Limited trades under three highly recognised brand names, OK Stores, Bon Marche’ Stores, and OKmart. The diverse distribution channel allows the Group to target all segments of the market.

OK Zimbabwe Limited has maintained its position as one of the dominant supermarket retailers in the country’s competitive retail sector. The OK Stores brand boasts 50 outlets nationwide in the major towns and cities around the country. The OK Stores cater for the widest range of customers within the OK Zimbabwe stable.

With the partnership with Contitouch Technologies through Conticash FX we are now able to deliver convenience to millions of Zimbabweans by providing them WorldRemit services within our stores across the country.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye